HECW1

gene
On this page

Also known as KIAA0322NEDL1

Summary

HECW1 (HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1, HGNC:22195) is a protein-coding gene on chromosome 7p14.1-p13, encoding E3 ubiquitin-protein ligase HECW1 (Q76N89). E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent degradation of DVL1.

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in regulation of dendrite morphogenesis and ubiquitin-dependent protein catabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm.

Source: NCBI Gene 23072 — RefSeq curated summary.

At a glance

  • GWAS associations: 12
  • Clinical variants (ClinVar): 232 total
  • MANE Select transcript: NM_015052

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:22195
Approved symbolHECW1
NameHECT, C2 and WW domain containing E3 ubiquitin protein ligase 1
Location7p14.1-p13
Locus typegene with protein product
StatusApproved
AliasesKIAA0322, NEDL1
Ensembl geneENSG00000002746
Ensembl biotypeprotein_coding
OMIM610384
Entrez23072

Gene structure

Transcript identifiers

Ensembl transcripts: 12 — 8 protein_coding_CDS_not_defined, 4 protein_coding

ENST00000395891, ENST00000429529, ENST00000453890, ENST00000461842, ENST00000464944, ENST00000471043, ENST00000471527, ENST00000481031, ENST00000490954, ENST00000492310, ENST00000493057, ENST00000857209

RefSeq mRNA: 2 — MANE Select: NM_015052 NM_001287059, NM_015052

CCDS: CCDS5469, CCDS69286

Canonical transcript exons

ENST00000395891 — 30 exons

ExonStartEnd
ENSE000014882274311264743112937
ENSE000015932344355222243552336
ENSE000015978804345082843450929
ENSE000016064264355459243554790
ENSE000016250184345629743456447
ENSE000016359424350896943509121
ENSE000016441984354116343541261
ENSE000016442794354186943541998
ENSE000016734454356181543566001
ENSE000016786284346366043463799
ENSE000016794854350069943500782
ENSE000017068254349308443493180
ENSE000017072854355044543550591
ENSE000017088994324387543243932
ENSE000017264624350801843508131
ENSE000017320684347961043479744
ENSE000017409354346892043469105
ENSE000017502694344421843445570
ENSE000017504594350713743507257
ENSE000017586074350121343501322
ENSE000017593324349207543492180
ENSE000017669604346644743466568
ENSE000017734574344252943442629
ENSE000022655014343800343438145
ENSE000022683864311415743114391
ENSE000034880094340756243407731
ENSE000035219804336088643360980
ENSE000035989404339681443396889
ENSE000036713264331176343312087
ENSE000036775744332063543320742

Expression profiles

Bgee: expression breadth ubiquitous, 172 present calls, max score 93.73.

FANTOM5 (CAGE): breadth broad, TPM avg 3.6338 / max 150.4080, expressed in 509 samples.

FANTOM5 promoters (15 alternative TSS)

Promoter IDTPM avgSamples expressed
783391.5132216
783510.4565203
783380.321089
783460.317967
783520.2937153
783360.237087
783470.099139
783420.083752
783440.070633
783370.061734

Top tissues by expression

284 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
Brodmann (1909) area 23UBERON:001355493.73gold quality
middle temporal gyrusUBERON:000277193.19gold quality
endothelial cellCL:000011591.83gold quality
primary visual cortexUBERON:000243687.31gold quality
cortical plateUBERON:000534386.00gold quality
occipital lobeUBERON:000202184.12gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.60gold quality
ganglionic eminenceUBERON:000402382.89gold quality
prefrontal cortexUBERON:000045182.83gold quality
frontal cortexUBERON:000187080.06gold quality
dorsolateral prefrontal cortexUBERON:000983479.81gold quality
superior frontal gyrusUBERON:000266179.51gold quality
ponsUBERON:000098879.46gold quality
neocortexUBERON:000195079.39gold quality
lateral nuclear group of thalamusUBERON:000273678.87gold quality
right frontal lobeUBERON:000281078.61gold quality
Brodmann (1909) area 9UBERON:001354078.39gold quality
parietal lobeUBERON:000187277.91gold quality
postcentral gyrusUBERON:000258177.29gold quality
cerebral cortexUBERON:000095676.99gold quality
Brodmann (1909) area 46UBERON:000648376.89silver quality
entorhinal cortexUBERON:000272875.41gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099175.39gold quality
cingulate cortexUBERON:000302774.98gold quality
anterior cingulate cortexUBERON:000983574.81gold quality
pancreatic ductal cellCL:000207974.58silver quality
buccal mucosa cellCL:000233673.71silver quality
ventricular zoneUBERON:000305373.61gold quality
embryoUBERON:000092273.53gold quality
calcaneal tendonUBERON:000370173.31gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-HCAD-25yes89.93
E-HCAD-35yes69.59
E-ANND-3yes7.36

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

102 targeting HECW1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-432-3P100.0067.86705
HSA-MIR-3064-3P100.0070.091254
HSA-MIR-3163100.0077.238605
HSA-MIR-3689D100.0066.141181
HSA-MIR-6851-5P100.0065.631294
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-118499.9968.191458
HSA-MIR-33A-5P99.9968.621055
HSA-MIR-33B-5P99.9968.581062
HSA-MIR-318599.9968.121959
HSA-MIR-453499.9966.581907
HSA-MIR-314899.9775.066478
HSA-MIR-60799.9773.625593
HSA-MIR-570-3P99.9672.414910
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-651-3P99.9473.485177
HSA-MIR-205-3P99.9269.923165
HSA-MIR-568099.9169.833421
HSA-MIR-806399.9169.763146
HSA-MIR-367199.9073.043897
HSA-MIR-3140-3P99.8868.472069
HSA-MIR-612499.8769.783551
HSA-MIR-6715A-3P99.8368.051473
HSA-MIR-442099.8270.081624
HSA-MIR-181B-2-3P99.8170.061646
HSA-MIR-181B-3P99.8170.061646
HSA-MIR-204-5P99.7971.622439
HSA-MIR-211-5P99.7971.652440
HSA-MIR-5002-5P99.7670.841763
HSA-MIR-62399.7668.161170

Literature-anchored findings (GeneRIF, showing 12)

  • interaction among misfolded SOD1, NEDL1, translocon-associated protein-delta, and Dishevelled-1 forms a ubiquitinated protein complex that is included in potentially cytotoxic protein aggregates (PMID:14684739)
  • functional interaction of NEDL1 with p53 might contribute to the induction of apoptosis in cancerous cells bearing wild-type p53. (PMID:18223681)
  • These findings suggest that the human NEDL1 transgenic mice might develop Amyotrophic lateral sclerosis-like symptoms, showing signs of motor abnormalities, accompanied with significant reduction in muscle strength. (PMID:20976258)
  • These findings suggest that RNF43 is associated with p53-mediated apoptosis in collaboration with NEDL1 in colorectal carcinogenesis. (PMID:21108931)
  • Ndel1 regulates Dyn2 GTPase activity and impacts GluR1-containing membranes distribution in a manner reminiscent of Dyn2. (PMID:21283621)
  • Ndel1 acts as a novel upstream regulator of the trichoplein-Aurora A pathway to inhibit primary cilia assembly. (PMID:26880200)
  • The ubiquitin E3 ligase HECW1 catalyzes TTF1 ubiquitination. (PMID:30849519)
  • Study reported for the first time that HECW1 mRNA levels were negatively correlated with Gd-IgA1 levels and pointed to a new regulatory mechanism of IgA nephropathy that can explain the aberrant glycosylation of IgA1. (PMID:31057023)
  • E3 ubiquitin ligase HECW1 promotes the metastasis of non-small cell lung cancer cells through mediating the ubiquitination of Smad4. (PMID:33529121)
  • Integrating HECW1 expression into the clinical indicators exhibits high accuracy in assessing the prognosis of patients with clear cell renal cell carcinoma. (PMID:34348693)
  • Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1. (PMID:36674783)
  • HECW1 induces NCOA4-regulated ferroptosis in glioma through the ubiquitination and degradation of ZNF350. (PMID:38049396)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriohecw1bENSDARG00000004291
danio_rerioHECW1ENSDARG00000100958
mus_musculusHecw1ENSMUSG00000021301
rattus_norvegicusHecw1ENSRNOG00000016046

Paralogs (24): UBE3C (ENSG00000009335), NEDD4L (ENSG00000049759), NEDD4 (ENSG00000069869), ITCH (ENSG00000078747), HACE1 (ENSG00000085382), HUWE1 (ENSG00000086758), HECTD1 (ENSG00000092148), UBR5 (ENSG00000104517), SMURF2 (ENSG00000108854), UBE3A (ENSG00000114062), AREL1 (ENSG00000119682), WWP1 (ENSG00000123124), HERC2 (ENSG00000128731), HECW2 (ENSG00000138411), HERC3 (ENSG00000138641), HERC6 (ENSG00000138642), HERC5 (ENSG00000138646), HERC4 (ENSG00000148634), UBE3B (ENSG00000151148), TRIP12 (ENSG00000153827), HECTD2 (ENSG00000165338), HECTD4 (ENSG00000173064), WWP2 (ENSG00000198373), SMURF1 (ENSG00000198742)

Protein

Protein identifiers

E3 ubiquitin-protein ligase HECW1Q76N89 (reviewed: Q76N89)

Alternative names: HECT, C2 and WW domain-containing protein 1, HECT-type E3 ubiquitin transferase HECW1, NEDD4-like E3 ubiquitin-protein ligase 1

All UniProt accessions (2): Q76N89, H7C3Q2

UniProt curated annotations — full annotation on UniProt →

Function. E3 ubiquitin-protein ligase that mediates ubiquitination and subsequent degradation of DVL1. Also targets the mutant SOD1 protein involved in familial amyotrophic lateral sclerosis (FALS). Forms cytotoxic aggregates with DVL1, SSR3 and mutant SOD1 that lead to motor neuron death in FALS.

Subunit / interactions. Interacts with DVL1 and SSR3. Also interacts with mutant SOD1.

Subcellular location. Cytoplasm.

Tissue specificity. Predominantly expressed in neurons of adult and fetal brain. Weakly expressed in the kidney.

Pathway. Protein modification; protein ubiquitination.

Isoforms (2)

UniProt IDNamesCanonical?
Q76N89-11yes
Q76N89-22

RefSeq proteins (2): NP_001273988, NP_055867* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000008C2_domDomain
IPR000569HECT_domDomain
IPR001202WW_domDomain
IPR032348HECW_NDomain
IPR035892C2_domain_sfHomologous_superfamily
IPR035983Hect_E3_ubiquitin_ligaseHomologous_superfamily
IPR036020WW_dom_sfHomologous_superfamily
IPR037795C2_HECWDomain
IPR040524HECW1_helixDomain
IPR050409E3_ubiq-protein_ligaseFamily

Pfam: PF00168, PF00397, PF00632, PF16562, PF18436

Enzyme classification (BRENDA):

  • EC 2.3.2.26 — HECT-type E3 ubiquitin transferase (BRENDA: 14 organisms, 64 substrates, 19 inhibitors, 5 Km, 5 kcat entries)

Substrate kinetics (BRENDA)

1 substrates with measured Km, best-characterized 1. Km ranges are aggregated across organisms/conditions.

SubstrateKm (mM)Measurements
[UBC5B]-L-LYSINE0.0046–0.0375

UniProt features (36 total): compositionally biased region 9, helix 6, region of interest 5, domain 4, modified residue 3, strand 3, chain 1, coiled-coil region 1, active site 1, splice variant 1, sequence conflict 1, turn 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
3L4HX-RAY DIFFRACTION1.8

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q76N89-F161.550.26

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 1574 (glycyl thioester intermediate)

Post-translational modifications (3): 874, 937, 939

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-4641258Degradation of DVL

MSigDB gene sets: 118 (showing top): GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN, GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN, GOBP_DENDRITE_DEVELOPMENT, TGGTGCT_MIR29A_MIR29B_MIR29C, ATACCTC_MIR202, GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_NEUROGENESIS, GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY, GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION, GOBP_CANONICAL_WNT_SIGNALING_PATHWAY, GOBP_DENDRITE_MORPHOGENESIS, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT, GOBP_CELL_PROJECTION_ORGANIZATION

GO Biological Process (4): ubiquitin-dependent protein catabolic process (GO:0006511), protein ubiquitination (GO:0016567), regulation of dendrite morphogenesis (GO:0048814), negative regulation of canonical Wnt signaling pathway (GO:0090090)

GO Molecular Function (4): ubiquitin protein ligase activity (GO:0061630), ubiquitin-protein transferase activity (GO:0004842), protein binding (GO:0005515), transferase activity (GO:0016740)

GO Cellular Component (2): cytoplasm (GO:0005737), cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
TCF dependent signaling in response to WNT1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
protein ubiquitination1
modification-dependent protein catabolic process1
protein modification by small protein conjugation1
regulation of anatomical structure morphogenesis1
dendrite morphogenesis1
regulation of dendrite development1
negative regulation of Wnt signaling pathway1
canonical Wnt signaling pathway1
regulation of canonical Wnt signaling pathway1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
ubiquitin-like protein transferase activity1
binding1
catalytic activity1
intracellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

1430 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
HECW1SSR4P51571887
HECW1NDFIP1Q9BT67823
HECW1DVL1O14640791
HECW1SOD1P00441747
HECW1UBE2KP27924598
HECW1RNF43Q68DV7585
HECW1UBE2SQ16763564
HECW1NEDD8Q15843554
HECW1PTENP60484506
HECW1A0A087WY85A0A087WY85479
HECW1RHOBTB3O94955446
HECW1WNT1P04628445
HECW1AGBL3Q8NEM8432
HECW1ST8SIA1Q92185428
HECW1ZC3H12CQ9C0D7427

IntAct

28 interactions, top by confidence:

ABTypeScore
ARRDC3WWP2psi-mi:“MI:0914”(association)0.770
LDLRAD4NEDD4psi-mi:“MI:0914”(association)0.690
VAX1HECW1psi-mi:“MI:0915”(physical association)0.560
LDLRAD4WWP2psi-mi:“MI:0914”(association)0.530
ENTREP3NEDD4psi-mi:“MI:0914”(association)0.530
PRRG4HECW1psi-mi:“MI:0407”(direct interaction)0.440
HECW1FBXL15psi-mi:“MI:0915”(physical association)0.400
HECW1psi-mi:“MI:0915”(physical association)0.370
HECW1SHANK3psi-mi:“MI:0915”(physical association)0.370
HECW1TSC1psi-mi:“MI:0915”(physical association)0.370
CACNA1AHECW1psi-mi:“MI:0915”(physical association)0.370
MPHOSPH8HCFC1psi-mi:“MI:0914”(association)0.350
FAM189BKLRG2psi-mi:“MI:0914”(association)0.350
LDLRAD4WWP2psi-mi:“MI:0914”(association)0.350
TMEM171STX6psi-mi:“MI:0914”(association)0.350
ZNF707LRP4psi-mi:“MI:0914”(association)0.350
ILDR1FBP1psi-mi:“MI:0914”(association)0.350
PRRG1GGCXpsi-mi:“MI:0914”(association)0.350
CUEDC1WWP2psi-mi:“MI:0914”(association)0.350
DLG3KIF1Bpsi-mi:“MI:0914”(association)0.350
ENTREP3WWP2psi-mi:“MI:0914”(association)0.350
HECW1VAX1psi-mi:“MI:0915”(physical association)0.000
GFI1BHECW1psi-mi:“MI:0915”(physical association)0.000
USP7HECW1psi-mi:“MI:0915”(physical association)0.000

BioGRID (44): HECW1 (Affinity Capture-MS), HECW1 (Affinity Capture-MS), UBC (Biochemical Activity), UBE2D1 (Reconstituted Complex), UBE2D2 (Reconstituted Complex), UBE2D3 (Reconstituted Complex), UBE2L3 (Reconstituted Complex), HECW1 (Biochemical Activity), UBE2J2 (Reconstituted Complex), DVL1 (Two-hybrid), HECW1 (Affinity Capture-MS), HECW1 (Affinity Capture-MS), HECW1 (PCA), HECW1 (Affinity Capture-Western), HECW1 (Affinity Capture-Western)

ESM2 similar proteins: A0A1B0GTS1, A0A1B0GWH4, A1A4L6, A1YGI6, A6NDR6, B8QB46, F1MJR8, F1QDF8, O35892, O35893, P09015, P15036, P15037, P23497, P52729, P59598, Q32NH9, Q3KRF1, Q3UM89, Q4G112, Q4V7E1, Q5M7N6, Q5ND04, Q5XIV2, Q5ZHX5, Q66IG8, Q6P1R3, Q6PCX9, Q6PJQ5, Q708W2, Q76I76, Q76I79, Q76N89, Q7M6U3, Q8AXQ4, Q8BVK9, Q8IUE0, Q8IUE1, Q8IWB6, Q8IXJ9

Diamond homologs: A0A8C0NGY6, A1CQG2, A1D3C5, A2A5Z6, A2QQ28, A9JRZ0, B0XQ72, B8N7E5, D3ZBM7, D6C652, E1B7Q7, E1C656, F1LP64, F1N6G5, F8W2M1, G0S9J5, G5E870, H2LBU8, O00308, O08759, O13834, O14326, O15033, P39940, P40985, P46934, P46935, P46937, P46938, P51593, P53119, Q03280, Q05086, Q08CZ0, Q09291, Q0CCL1, Q14669, Q15034, Q15386, Q1K9C4

SIGNOR signaling

2 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”HECW1ubiquitination
HECW1“down-regulates quantity by destabilization”DVL1ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

232 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance198
Likely benign3
Benign4

Top pathogenic / likely-pathogenic (0)

SpliceAI

8285 predictions. Top by Δscore:

VariantEffectΔscore
7:43138287:GCT:Gdonor_gain1.0000
7:43219518:G:GGdonor_gain1.0000
7:43312048:G:GTdonor_gain1.0000
7:43312085:TTG:Tdonor_gain1.0000
7:43312085:TTGG:Tdonor_loss1.0000
7:43312086:TGG:Tdonor_loss1.0000
7:43312088:GTG:Gdonor_loss1.0000
7:43312089:T:Gdonor_loss1.0000
7:43312090:GAG:Gdonor_loss1.0000
7:43320611:T:TAacceptor_gain1.0000
7:43320624:T:TAacceptor_gain1.0000
7:43320625:G:Aacceptor_gain1.0000
7:43320632:T:Gacceptor_gain1.0000
7:43320632:TA:Tacceptor_loss1.0000
7:43320633:A:AGacceptor_gain1.0000
7:43320633:AGAT:Aacceptor_gain1.0000
7:43320634:G:GAacceptor_gain1.0000
7:43320634:GA:Gacceptor_gain1.0000
7:43320634:GAT:Gacceptor_gain1.0000
7:43320634:GATG:Gacceptor_gain1.0000
7:43320634:GATGA:Gacceptor_gain1.0000
7:43320738:GGAAC:Gdonor_gain1.0000
7:43320739:GAAC:Gdonor_gain1.0000
7:43320739:GAACG:Gdonor_gain1.0000
7:43320740:A:Tdonor_gain1.0000
7:43320740:AAC:Adonor_gain1.0000
7:43320741:AC:Adonor_gain1.0000
7:43320741:ACG:Adonor_loss1.0000
7:43320742:CGT:Cdonor_loss1.0000
7:43320743:G:GGdonor_gain1.0000

AlphaMissense

10572 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
7:43311977:T:AL81H1.000
7:43311977:T:CL81P1.000
7:43312033:T:AW100R1.000
7:43312033:T:CW100R1.000
7:43312034:G:CW100S1.000
7:43312035:G:CW100C1.000
7:43312035:G:TW100C1.000
7:43312040:T:AI102K1.000
7:43312063:G:CD110H1.000
7:43312064:A:CD110A1.000
7:43312064:A:TD110V1.000
7:43312066:T:AW111R1.000
7:43312066:T:CW111R1.000
7:43312070:T:AI112N1.000
7:43312072:G:CG113R1.000
7:43312073:G:AG113D1.000
7:43312078:T:GY115D1.000
7:43320673:C:AR131S1.000
7:43320709:T:AW143R1.000
7:43320709:T:CW143R1.000
7:43360904:T:CF160S1.000
7:43360909:T:CY162H1.000
7:43360909:T:GY162D1.000
7:43360912:T:GY163D1.000
7:43360939:G:CA172P1.000
7:43360961:T:AV179D1.000
7:43407580:T:CL217S1.000
7:43407580:T:GL217W1.000
7:43407588:G:AG220R1.000
7:43407588:G:CG220R1.000

dbSNP variants (sampled 300 via entrez): RS1000005560 (7:43328138 T>C), RS1000007825 (7:43269349 G>T), RS1000015538 (7:43417401 A>C,G,T), RS1000023021 (7:43183963 A>T), RS1000027188 (7:43143091 C>T), RS1000027717 (7:43446550 G>A), RS1000033341 (7:43278192 A>G), RS1000048260 (7:43417625 G>A), RS1000049934 (7:43196752 G>A), RS1000058465 (7:43187913 G>A,C), RS1000059528 (7:43114033 T>G), RS1000060676 (7:43547105 C>T), RS1000065344 (7:43221565 T>C,G), RS1000082319 (7:43306480 C>A,T), RS1000084550 (7:43523994 A>G)

Disease associations

OMIM: gene MIM:610384 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

12 associations (top):

StudyTraitp-value
GCST001762_407Obesity-related traits6.000000e-06
GCST001915_44Alzheimer’s disease (cognitive decline)1.000000e-06
GCST002560_4Type 2 diabetes4.000000e-06
GCST002927_9Mercury levels7.000000e-06
GCST003072_4Cerebrospinal fluid AB1-42 levels3.000000e-07
GCST003654_12Bone mineral density (Ward’s triangle area)5.000000e-06
GCST004159_4Serum galactose-deficient IgA1 levels6.000000e-06
GCST004749_18Lung cancer in ever smokers7.000000e-06
GCST005851_27Delirium5.000000e-06
GCST006535_5Irritable bowel syndrome4.000000e-06
GCST008257_4Diverticular disease1.000000e-06
GCST009175_8Caudal anterior-cingulate cortex volume3.000000e-06

EFO canonical traits (4, from GWAS)

EFO IDTrait name
EFO:0003939energy intake
EFO:0004670beta-amyloid 1-42 measurement
EFO:0007785femoral neck bone mineral density
EFO:0009959diverticular disease

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs10255565HECW10.000

CTD chemical–gene interactions

20 total (human), top 20 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyreneaffects methylation, increases mutagenesis3
bisphenol Adecreases methylation, increases expression2
methylmercuric chlorideincreases expression1
ethyl-p-hydroxybenzoateincreases expression1
sulforaphaneincreases expression1
sodium arseniteincreases expression1
benzo(e)pyrenedecreases methylation1
aflatoxin B2decreases methylation1
2-palmitoylglycerolincreases expression1
abrinedecreases expression1
Bortezomibincreases expression, increases response to substance1
Resveratrolaffects cotreatment, decreases expression1
Arsenicaffects methylation1
Estradiolaffects cotreatment, increases expression1
Methapyrilenedecreases methylation1
Plant Extractsaffects cotreatment, decreases expression1
Rotenonedecreases expression1
Thimerosalincreases expression1
Valproic Acidincreases methylation1
Aflatoxin B1increases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): delirium, irritable bowel syndrome